<p>Raoufi Global Group of Companies was recognized and awarded as the best pharmaceutical company of Afghanistan by Afghanistan Food and Drugs Authority.</p> | Date: Jan 11, 2024
The Raoufi Global Group of Companies (RGGC) received the award for its quality and standards in the field of pharmaceuticals.
RGGC recently organized a business conference, bringing together government officials, national and international businessmen, doctors and foreign guests.
The event at Serena Hotel in Kabul was also attended by representatives from different companies to explore advancements,, innovations, changes, developments and achievements in the pharmaceutical sector.
The conference started based on an academic, professional and commercial schedule. Mr. Yaqoob Mangal, head of the Afghanistan Entrepreneurs’ Union, expressed gratitude to the government for prohibiting free trade and smuggling.
He emphasized the positive impact of the recent initiatives of AFDA on medicine quality control and restricting imports to registered companies.
Foreign speakers and company directors pledged support for RGGC initiatives, development, quality and specialized services, committing to the launch of new portfolios in Afghanistan, reinforcing their backing for the Afghan pharma industry.
Mr. Ehsanullah Sediq, AFDA’s Licensing and Registration Head, highlighted AFDA efforts in defining industry standards and developments in establishment of practical quality-control mechanisms.
AFDA’s work has curbed the import of illegal medical equipment and medicine, revealed plans for new testing laboratories in major Afghan cities for speedy QC analysis and improved quality assurance.
Mr. Sediq welcomed national and international input and support for enhancing the country’s pharmaceutical infrastructure.
Officials of the National Food and Drug Administration of Afghanistan praised this company for meeting national and international standards and hailed it as the most famous import firm of Afghanistan. It also received the best company award.
At the end of the conference, CEO of Raoufi Group of Companies. Said Abass Raoufi, thanked the National Food and Drug Authority for its initiatives, and praised the team members and colleagues for their progress and achievements.
He revealed plans to import chronic products, addressing Afghanistan’s needs with US-FDA approved items. This initiative aims to alleviate the deficit of essential products, prioritizing quality and compliance.
Mr. Raoufi is working on an exciting initiative, which will create a regular network of supply chain for medicine transfers according to GSP standards to all provinces. It will also ensure the quality of medicine.
This group wants to bring another change to insulin medicine in the country. Based on need, quality insulin drugs will be safely imported and prescribed according to the instructions of doctors and in close coordination with the AFDA...